Atara Biotherapeutics, Inc. - Common Stock (ATRA)
CUSIP: 046513107
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,165,808
- Total 13F shares
- 93,317,058
- Share change
- +4,179,528
- Total reported value
- $1,470,768,390
- Put/Call ratio
- 19%
- Price per share
- $15.76
- Number of holders
- 137
- Value change
- +$63,749,519
- Number of buys
- 60
- Number of sells
- 61
Quarterly Holders Quick Answers
What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 046513107:
Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAUPOST GROUP LLC/MA |
13F
|
Company |
104%
|
8,477,488
|
$151,747,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
98%
|
8,015,817
|
$143,483,000 | — | 30 Sep 2021 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
96%
|
7,855,824
|
$140,619,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
94%
|
7,651,591
|
$136,963,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
83%
|
6,800,583
|
$121,730,000 | — | 30 Sep 2021 | |
| Redmile Group, LLC |
13F
|
Company |
79%
|
6,466,277
|
$115,746,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
55%
|
4,482,535
|
$80,238,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
46%
|
3,780,897
|
$67,678,000 | — | 30 Sep 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
36%
|
2,907,511
|
$52,044,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
35%
|
2,874,277
|
$51,450,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
34%
|
2,809,760
|
$50,295,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
28%
|
2,318,300
|
$41,498,000 | — | 30 Sep 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
22%
|
1,781,234
|
$31,885,000 | — | 30 Sep 2021 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
18%
|
1,509,728
|
$27,024,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
18%
|
1,500,000
|
$26,850,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
18%
|
1,472,822
|
$26,363,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
13%
|
1,060,739
|
$18,987,000 | — | 30 Sep 2021 | |
| Antipodean Advisors LLC |
13F
|
Company |
13%
|
1,050,000
|
$18,795,000 | — | 30 Sep 2021 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
11%
|
926,588
|
$16,586,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
11%
|
910,928
|
$16,305,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
11%
|
860,739
|
$15,409,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
10%
|
843,249
|
$15,094,000 | — | 30 Sep 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
10%
|
831,907
|
$14,891,000 | — | 30 Sep 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
9.2%
|
751,973
|
$13,462,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
9.2%
|
750,614
|
$13,436,000 | — | 30 Sep 2021 | |
| Alberta Investment Management Corp |
13F
|
Company |
7.3%
|
598,330
|
$10,710,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
7.2%
|
584,529
|
$10,464,000 | — | 30 Sep 2021 | |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC |
13F
|
Company |
6.4%
|
525,000
|
$9,397,000 | — | 30 Sep 2021 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
5.5%
|
451,827
|
$8,088,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
5.4%
|
444,400
|
$7,955,000 | — | 30 Sep 2021 | |
| Lion Point Capital, LP |
13F
|
Company |
4.3%
|
350,465
|
$6,273,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
3.7%
|
303,183
|
$5,427,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
3.7%
|
303,030
|
$5,424,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.4%
|
281,679
|
$5,042,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
3.4%
|
274,397
|
$4,912,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
3.3%
|
270,849
|
$4,848,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
3.1%
|
250,253
|
$4,480,000 | — | 30 Sep 2021 | |
| STALEY CAPITAL ADVISERS INC |
13F
|
Company |
3.1%
|
250,000
|
$4,475,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
3%
|
246,136
|
$4,406,000 | — | 30 Sep 2021 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.4%
|
200,000
|
$3,580,000 | — | 30 Sep 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
2.4%
|
193,000
|
$3,455,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
1.9%
|
157,900
|
$2,826,000 | — | 30 Sep 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
1.8%
|
150,401
|
$2,692,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
1.7%
|
135,320
|
$2,422,000 | — | 30 Sep 2021 | |
| NATIXIS |
13F
|
Company |
1.6%
|
127,700
|
$2,286,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
1.5%
|
126,037
|
$2,256,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
1.5%
|
122,717
|
$2,197,000 | — | 30 Sep 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
116,900
|
$2,093,000 | — | 30 Sep 2021 | |
| Trellus Management Company, LLC |
13F
|
Company |
1.3%
|
105,100
|
$1,881,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
104,230
|
$1,866,000 | — | 30 Sep 2021 |
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2021
As of 31 Dec 2021,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,317,058 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, MAVERICK CAPITAL LTD, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, Redmile Group, LLC, FMR LLC, Point72 Asset Management, L.P., STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This page lists
137
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
138
Q4 2021 holders
137
Holder diff
-1
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.